Specialty Services in Community Pharmacies—What to Consider Please read through the following information and click Continue.
ACPE Universal Program Number: 207-0000-16-003-H04-P; 207-0000-16-003-H04-T Release Date: March 1, 2016 Expiration Date: March 1, 2019 Activity Type: Application-based
Statement of Need Specialty medications have caused everyone from presidential candidates, the Wall Street Journal and most major news agencies to turn their heads; not to mention the spinning heads of employers and their health plan partners over what looks like an amazing opportunity to manage costs. Although the marketplace is relatively undefined because there is no consensus definition of a specialty medication, we can think of the "specialty" class as including medications that are usually high-cost and have at least one characteristic that make them significantly more complex than a "traditional" medication. There are many potential goals for an independent pharmacy to strive for when considering entering the specialty marketplace. There are also many potential issues or barriers that may stand in the way of achieving those goals. Evaluation and understanding of these potential issues before starting the process of specialty implementation can make them significantly less problematic later on.
Pharmacists Learning Objectives Upon successful completion of this activity, pharmacists should be better able to:
Pharmacy Technicians Learning Objectives Upon successful completion of this activity, pharmacy technicians should be better able to:
Any medications or treatment methods suggested in this activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication. This article contains a discussion of off-label uses that will be identified as such by the author.
Target Audience The target audience for this activity is Pharmacists and Pharmacy Technicians.
Instructions for Participation To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee There is no fee for this activity.
Faculty Kevin Day, PharmD, RPh, is the NCPA executive resident.
Disclosure Declaration It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.
The authors, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
MAC Safari (Latest Version) Firefox (Latest Version) *Adobe Acrobat Reader